Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 5/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | DAO | P14920 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27625488 | 0.85 | MMP2 (0.67) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL13612673 | 0.85 | MAOA (0.61) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL30594160 | 0.83 | MAOB (0.67) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL1619109 | 0.83 | MAOB (0.67) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL25306495 | 0.81 | MAOA (0.58) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL765821 | 0.81 | MAOA (0.58) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL3009674 | 0.81 | HPGD (0.59) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL29934196 | 0.81 | POLB (0.59) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL294595 | 0.81 | MAOA (0.58) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL1992302 | 0.81 | MAOA (0.58) | MAOAMAOBMMP2MMP9ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090197910-A1 | NOVEL VIRAL REPLICATION INHIBITORS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2009-08-06 | — | — | US | claimed |
| EP-2032541-A2 | NOVEL VIRAL REPLICATION INHIBITOR | Katholieke Universiteit Leuven Research & Development (BE) | 2009-03-11 | — | — | EP | claimed |
| WO-2007128086-A2 | NOVEL VIRAL REPLICATION INHIBITOR | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2007-11-15 | — | — | WO | claimed |
| WO-2018203315-A1 | METHOD FOR MICROORGANISM EXTRACTION AND/OR FOR DETERMINATION OF A MICROORGANISM MAIN RESISTANCE MECHANISM AND/OR THE MINIMUM INHIBITORY CONCENTRATION OF A THERAPEUTICAL AGENT, KITS AND USES THEREOF | UNIVERSIDADE DO PORTO (PT) | 2018-11-08 | — | — | WO | disclosed |
| CN-102245201-B | Adjuvant in immunonanotherapeutics is integrated | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-01-20 | — | — | CN | disclosed |
| US-9238712-B2 | Tagged polymers and methods of use | Empire Technology Developments LLC (US) | 2016-01-19 | — | — | US | disclosed |
| US-20140039147-A1 | TAGGED POLYMERS AND METHODS OF USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-02-06 | — | — | US | disclosed |
| WO-2014021892-A2 | TAGGED POLYMERS AND METHODS OF USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-02-06 | — | — | WO | disclosed |
| US-8383843-B2 | Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-02-26 | — | — | US | disclosed |
| US-8383843-B2 | Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-02-26 | — | — | US | disclosed |
| US-8383843-B2 | Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-02-26 | — | — | US | disclosed |
| US-20120088923-A1 | METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-04-12 | — | — | US | disclosed |
| US-20120088923-A1 | METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-04-12 | — | — | US | disclosed |
| US-20090197910-A1 | NOVEL VIRAL REPLICATION INHIBITORS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2009-08-06 | — | — | US | disclosed |
| EP-2032541-A2 | NOVEL VIRAL REPLICATION INHIBITOR | Katholieke Universiteit Leuven Research & Development (BE) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007128086-A2 | NOVEL VIRAL REPLICATION INHIBITOR | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2007-11-15 | — | — | WO | disclosed |
| US-6927283-B2 | Modified acyl carrier proteins | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050118668-A1 | MODIFIED ACYL CARRIER PROTEINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-06-02 | — | — | US | disclosed |
| US-5741662-A | Direct stain specific binding assays for microorganisms | QUIDEL CORPORATION (US) | 1998-04-21 | — | — | US | disclosed |
| WO-1997022714-A1 | DIRECT STAIN SPECIFIC BINDING ASSAYS FOR MICROORGANISMS | QUIDEL CORPORATION (US) | 1997-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088923-A1 | METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND | CYP3A7, CYP2A7, F7 | MAOA 428/4885MAOB 327/4885MMP2 2719/4885 |
| US-20090197910-A1 | NOVEL VIRAL REPLICATION INHIBITORS | EIF2AK2, MAVS, ZC3HAV1 | MAOA 2935/4885MAOB 2451/4885MMP2 3575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.